Table 2. Results of laboratory parameters in COVID-19 patients and control group.
Laboratory parameter | Control group (mean ± SD) | COVID-19 patient group (mean ± SD) | p value |
---|---|---|---|
Red blood cell distribution width‐CV (RDW-CV)(%) | 12.8±0.7 | 13.6±1.3 | 0.000* |
Mean platelet volume (MPV), fl | 10.3±0.94 | 10.1±1.06 | 0.387 |
PVI (MPV/platelet ratio) | 3.2±1.2 | 5.7±2.5 | 0.000* |
Total protein (65‐85 g/L) | 73.2±4.5 | 69.8±7.8 | 0.048 |
Albumin (40‐55 g/L) | 46.13±2.5 | 39.8±4.8 | 0.000* |
LDH, U/L | 172.5±26 | 247.6±55.2 | 0.000* |
Ferritin, mL/ng | 364.5±54.4 | 58.4±49.9 | 0.003* |
C‐reactive protein (0-6 mg/L) | 1.5±0.9 | 53.12±10.4 | 0.010* |
Hemoglobin, g/L | 14.2±1.2 | 13.8±1.8 | 0.276 |
Platelet x109/L | 293±55.2 | 209.4±58.3 | 0.000* |
WBC (4.0‐10.0×109/L) | 7.2±1.3 | 10.04±3.8 | 0.023* |
Neutrophil (2.0‐6.0×109/L) | 4.1±1.23 | 5.7±3.5 | 0.013* |
Lymphocyte (1.1‐3.2×109/L) | 2.3±0.7 | 1.6±0.9 | 0.000* |
SD = standard deviation; PVI = platelet volume index; LDH = L-lactate dehydrogenase; WBC = white blood count; Mann-Whitney U test was used on statistical analysis; *p<0.05 was considered significant